RxSight, Inc.
RXST
$12.62
-$0.47-3.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.34M | 33.64M | 37.90M | 40.21M | 35.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.34M | 33.64M | 37.90M | 40.21M | 35.31M |
| Cost of Revenue | 6.11M | 8.45M | 9.57M | 11.43M | 10.09M |
| Gross Profit | 24.23M | 25.19M | 28.33M | 28.79M | 25.22M |
| SG&A Expenses | 27.35M | 28.98M | 28.64M | 28.22M | 25.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.52M | 47.64M | 48.57M | 48.84M | 44.54M |
| Operating Income | -12.18M | -14.00M | -10.67M | -8.63M | -9.23M |
| Income Before Tax | -9.81M | -11.75M | -8.17M | -5.93M | -6.33M |
| Income Tax Expenses | 10.00K | 32.00K | 18.00K | 12.00K | 13.00K |
| Earnings from Continuing Operations | -9.82M | -11.79M | -8.19M | -5.94M | -6.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.82M | -11.79M | -8.19M | -5.94M | -6.34M |
| EBIT | -12.18M | -14.00M | -10.67M | -8.63M | -9.23M |
| EBITDA | -11.32M | -13.22M | -9.90M | -8.11M | -8.09M |
| EPS Basic | -0.24 | -0.29 | -0.20 | -0.15 | -0.16 |
| Normalized Basic EPS | -0.15 | -0.18 | -0.13 | -0.09 | -0.10 |
| EPS Diluted | -0.24 | -0.29 | -0.20 | -0.15 | -0.16 |
| Normalized Diluted EPS | -0.15 | -0.18 | -0.13 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 40.97M | 40.74M | 40.51M | 40.36M | 39.79M |
| Average Diluted Shares Outstanding | 40.97M | 40.74M | 40.51M | 40.36M | 39.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |